Oncology News, Insights, Stories by OncoDaily

AACR IO Conference 2026
2026-02-18 08:00 - 2026-02-21 17:00 (America/Halifax) | JW Marriott Los Angeles L.A. Live, 900 W Olympic Blvd, Los Angeles, CA, Los Angeles, 90015, United States
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live.
Led by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas, the event will focus on cutting-edge research in cancer immunology, highlighting breakthroughs in immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies.
Building on the success of AACR IO 2025, which drew over 600 participants, AACR IO 2026 promises a comprehensive program including keynote lectures, symposia, spotlight sessions, educational content, and poster presentations. This forum offers a valuable opportunity for scientists, clinicians, industry leaders, and advocates to engage with the latest advances in cancer immunotherapy.
More posts featuring AACR.

2026 International Cancer Neuroscience Symposium
2026-02-18 08:15 - 2026-02-20 19:00 (America/Halifax) | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley’s Advanced Portfolio, is a three-day dynamic hybrid event scheduled for Wednesday, February 18, to Friday, February 20, 2026.
The in-person component will be held at the TMC3 Collaborative Building in Houston, Texas. This biennial symposium aims to integrate the fields of oncology, neuroscience, cancer biology, neuroimmunology, and mental health, bringing together over 30 leading international experts to share key insights and cutting-edge research to foster innovation in cancer research and enhance patient care.
Register.

2026 Multidisciplinary Head and Neck Cancers Symposium by ASTRO
2026-02-19 - 2026-02-21 | JW Marriott Desert Springs Resort and Spa, 74-855 Country Club Dr., Palm Desert, CA, 92260, United States
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies, the symposium will be held both in-person in Palm Desert, California, and as a live virtual meeting online.
The central theme for the 2026 meeting is “Advancing Patient-Centered Care Through Innovative Team Science.” The conference aims to foster meaningful collaboration among radiation oncologists, medical oncologists, surgeons, and other specialists to share the most current, evidence-based practices in the field.
The program is structured to deliver practical insights through educational sessions, interactive case discussions, and oral abstract presentations. It serves as a forum for presenting and discussing new data, with the Call for Abstracts remaining open until October 8, 2025. The core objective of the symposium is to improve patient outcomes by advancing multidisciplinary treatment approaches and team-based care for head and neck cancers. Registration and housing are currently open for attendees.

Advocates Webinar: Modernizing Oncology Endpoints
2026-02-19 12:00 - 13:00 (America/Halifax)
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 PM ET.
The webinar will build upon the public meeting held earlier in the month, focusing on translating complex scientific and policy discussions into accessible, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments.
Register.

APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the Circa Resort and Casino in Las Vegas, Nevada.
The summit is specifically tailored for Advanced Practice Providers (APPs), including Nurse Practitioners (NPs), Physician Assistants (PAs), pharmacists, and nurses, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer.
Register.

Highlights in GI Oncology
2026-02-20 - 2026-02-21 | Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL, 32821, United States
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium.
The CME initiative, designed for a multidisciplinary audience including oncologists, surgeons, and nurses, is scheduled for February 20–21, 2026, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers, including colorectal, pancreatic, biliary, and neuroendocrine cancers, applying the findings to patient case contexts.
Register.

Oncology APP Leadership Forum 2026
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology.
Scheduled for February 20–21, 2026, at the Circa Resort and Casino in Las Vegas, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace, utilizing AI in leadership, constructing an APP billing dashboard, building leadership education frameworks, and a workshop on burnout and boundary setting.
Register.

16th World ADC London
2026-02-23 - 2026-02-26 | ExCeL London, One Western Gateway, Royal Victoria Dock, London, E16 1XL, United Kingdom
﻿The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance.
The summit will host over 800 senior European ADC decision-makers, including biopharma executives, clinicians, investors, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs, specifically highlighting novel cytotoxic and non-cytotoxic payloads, dual/bispecific ADCs, non-antibody conjugates, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact.
The 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking, offering comprehensive One-on-One Partnering and informal networking opportunities, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content.
View the 2026 agenda here.
Registration link.
Full Event Guide link.
You can find more posts on ADCs on OncoDaily.

Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
2026-02-24 - 2026-02-25 | London SW7 2AZ
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026.
The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment.
The program will feature invited talks from leading scientists on innovative therapeutic strategies, including novel NK, T, and myeloid cell therapies, mRNA therapies, cytokine targeting, and new combinatorial immune checkpoint blockade strategies.

9th CAR-TCR Summit Europe 2026
2026-02-24 - 2026-02-26 | Park Plaza Victoria London, 239 Vauxhall Bridge Road, London, Greater London (England), SW1V 1EQ, United Kingdom
The 9th CAR-TCR Summit Europe 2026 is the essential, industry-dedicated forum for next-generation cell therapy, scheduled from February 24–26, 2026, in London, UK, at the Park Plaza Victoria hotel. Organized by Hanson Wade, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies, including novel CAR, TCR, NK, and Macrophage designs, engineering to improve durability, and solutions to overcome bottlenecks in manufacturing, regulatory approval, and commercialization.
Full Event Guide Link.

Colorectal Liver Metastasis Consensus Conference
2026-02-24 - 2026-02-26 | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday, February 24, to Thursday, February 26, 2026, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston, Texas.
Hosted by The University of Texas MD Anderson Cancer Center, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases, culminating in a consensus statement brought forth by leading experts, clinicians, and researchers in the field.
Register.

ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
2026-02-25
The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases.
The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice, such as optimal biomarker testing, the integration of immunotherapy, and the management of treatment-related toxicities.
Register.

2026 ASCO GU Cancers Symposium
2026-02-26 - 2026-02-28 | Moscone West, 800 Howard Street, San Francisco, United States
The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28, 2026, at Moscone West in San Francisco, California.
This premier event, hosted by the American Society of Clinical Oncology (ASCO), will focus on the latest advancements in the prevention, diagnosis, and treatment of genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. The symposium will feature groundbreaking research presentations, expert-led educational sessions, and in-depth discussions on key topics in GU oncology.
Attendees can expect a rich program that combines plenary lectures, oral abstract presentations, poster sessions, and interactive workshops. The event emphasizes multidisciplinary collaboration, bringing together medical oncologists, urologists, radiation oncologists, pathologists, advanced practice providers, nurses, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology, immunotherapy, novel targeted therapies, survivorship, and health equity in GU cancers, highlighting both scientific innovation and patient-centered care.
The symposium also offers networking opportunities with leading global experts, enabling participants to exchange knowledge, discuss challenges, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available, allowing wider access for international participants.
Registration.
You can find more posts featuring ASCO on OncoDaily.

2026 Translating Evidence to Action: Elevating Cancer Care
2026-02-26 09:00 - 17:00 (America/Halifax)
The “2026 Translating Evidence to Action: Elevating Cancer Care“ is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK), scheduled as a live virtual conference on Thursday, February 26, 2026.
This program is designed for healthcare professionals across all disciplines to explore how evidence-based research can be translated into meaningful quality improvements in clinical practice and patient outcomes. The conference features exemplary quality improvement projects, practice-based initiatives, two dynamic Rapid-Fire Poster Sessions, and a keynote address on “Technology with a Human Pulse: Advancing Patient Care with Innovation and Intention.” Participants can earn up to 6.50 AMA PRA Category 1 Credits.
Register.

Updates on Advanced Breast Cancer: Local Management and Other New Perspectives
2026-02-27 - 2026-02-28 | Houston Marriott Medical Center/Museum District, 6580 Fannin Street, Driveway Entrance on, 1730 Dryden Rd, Houston, TX, 77030, United States
The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day, in-person event scheduled for February 27–28, 2026, at the Houston Marriott Medical Center in Houston, TX.
Hosted by The University of Texas MD Anderson Cancer Center, the activity’s main goal is to emphasize the integration of novel therapies and diagnostic tools into clinical practice, focusing on areas like liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC).
Register.

Call-on Congress by Fight Colorectal Cancer
2026-03-01 17:00 - 2026-03-03 21:00 (America/Halifax) | Hilton Arlington National Landing, 2399 Richmond Highway Arlington, VA 22202 United States, Arlington, VA, 22202, United States
Now in its 20th year, Call-on Congress is Fight Colorectal Cancer’s (Fight CRC) signature advocacy event – founded on Nancy Roach’s belief that patients must have a seat at the policy table. Each year, patients, survivors, caregivers, and healthcare professionals gather in Washington, D.C. to meet with lawmakers, share their stories, and drive policy change.
Registration Includes:

Fight CRC swag bag
Virtual and in-person advocacy training
Exclusive advocacy resources
Scheduled congressional meetings
Meals (Mon: breakfast and lunch | Tue: breakfast and dinner)

Preparation Tips:

Review training materials and key talking points in advance
Join the Community of Champions for updates, hotel info, and volunteer opportunities
Wear blue! Casual for training, business casual for Capitol Hill, and comfortable shoes

Hotel and Scholarships:
Discounted hotel rooms are available for $185/night.
Scholarships are offered to make attendance accessible:

Advocate Travel Scholarship for adults
Junior Advocate Leadership Scholarship for youth (ages 13–18) and a parent/guardian.

You can find more posts featuring Fight Colorectal Cancer.

ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich
2026-03-04 - 2026-03-05 | Zurich, Switzerland
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer.
The event is scheduled to take place on March 4–5, 2026, in Zurich, Switzerland.
The application deadline for participation is January 7, 2026, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing, using results for optimal patient selection, and discussing the proactive management of precision-medicine-based treatments.
Apply.

Provider Education Series - Lung Health Foundation
2026-03-05 13:00 - 14:00 (America/Halifax) | London SW7 2AZ
The Lung Health Foundation is offering a free, accredited virtual “Lunch and Learn” series – the Provider Education Series – consisting of three one-hour sessions designed to deliver high-impact, evidence-based education to healthcare professionals.
These sessions will provide practical insights from expert speakers on the diagnosis, treatment, and management of lung diseases, with a focus on severe asthma, COPD, and lung cancer. Participants will enhance their clinical knowledge, receive updates on current lung cancer risk assessment and screening guidelines, and earn valuable CPD credits to support best practices.

Session 1: September 18, 2025: What You Need to Know – Managing Severe Asthma in Your Practice
Session 2: November 27th, 2025: What You Need to Know – Optimizing COPD Treatment and Reducing Exacerbations in Your Practice
Session 3: March 5th, 2026: What You Need to Know – Managing Lung Cancer Risk Assessment in Your Practice

APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit
2026-03-06 - 2026-03-07 | The Ballantyne Hotel, Charlotte, Ballantyne Commons Parkway Charlotte, Charlotte, 28277, United States
The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7, 2026, bringing oncology clinicians together for a focused, two-day CE program dedicated to the latest advances in cancer care.
Designed with and for advanced practice providers, this summit delivers evidence-based updates, practical management strategies, and collaborative learning to strengthen patient care and team communication across the oncology continuum.
Register.

Pathology Update 2026
2026-03-06 - 2026-03-08 | International Convention Centre Sydney, Australia, 14 Darling Dr, Sydney NSW 2000, Australia, Sydney, NSW, 2000, Australia
Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8, 2026, in Sydney, NSW.
The meeting provides a multi-disciplinary pathology program for pathologists, scientists, and trainees, focusing on new developments and challenges in the field under the theme, “Many Paths. Shared Focus. Stronger Together.” The event will include plenary sessions, workshops, and abstract presentations from both local and international pathology experts, coinciding with the celebration of the RCPA’s 70th anniversary.

26th Multidisciplinary Management of Cancers: A Case-Based Approach
2026-03-06 08:00 - 2026-03-08 12:15 (America/Halifax) | The Meritage Resort and Spa, 875 Bordeaux Way, Napa, CA, 94558, United States
The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology.
The meeting features tumor board–style case discussions across breast, gastrointestinal, genitourinary, hematologic, lymphoma, and thoracic cancers, led by faculty and expert panels from Stanford, UC Davis, UC San Francisco, and the broader oncology community.
Register here.

OPN Pacific Northwest Chapter Conference 2026
2026-03-07 | Crowne Plaza Portland-Downtown Conv Ctr, 1441 NE 2nd Ave, Portland, OR, 97232, United States
The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network, scheduled for March 7, 2026.
The conference will be held at the Crowne Plaza in Portland, Oregon, United States. Designed for hematology/oncology pharmacy clinicians, including pharmacists and technicians, the event provides a platform to network, collaborate, and share the latest evidence-based strategies and best practices to advance patient care within the oncology pharmacy field.
Register.

ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
2026-03-11 - 2026-03-13 | Manchester, United Kingdom
The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom.
The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points.
The learning objectives cover the full spectrum of thoracic oncology, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC), with a focus on advanced treatments like targeted agents for actionable driver mutations, novel immunotherapies, and palliative care.
Apply.

12th ImmunoTherapy of Cancer Conference (ITOC12)
2026-03-12 - 2026-03-14 | Medical Center Großhadern of Ludwig-Maximilian-University, Marchioninistrasse 15, Munich, 81377, Germany
The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups, including the ITOC Association, the Tumor Centre in Munich (TZM), and the German Cancer Consortium (DKTK), the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.

The ESMO Sarcoma and Rare Cancers Congress 2026
2026-03-12 08:00 - 2026-03-14 17:00 (Europe/Zurich) | “Palazzo dei Congressi” in Lugano, Switzerland, Piazza Indipendenza 4, Lugano, 6900, Switzerland
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours.
The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations, educational lectures, multidisciplinary tumour boards, guidelines updates, and dedicated discussions for young oncologists. With opportunities for clinicians, researchers, industry professionals, and patient advocates to connect and collaborate, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.

APPOS Boston 2026: Advanced Practice Providers Oncology Summit
2026-03-13 - 2026-03-14 | The Westin Waltham Boston, 70 Third Ave., Waltham, MA, 02451, United States
The APPOS Boston 2026: Advanced Practice Providers Oncology Summit returns to Massachusetts, a two-day continuing education conference taking place March 13–14, 2026, in Waltham.
Designed for advanced practice providers, this program delivers the latest updates in multidisciplinary cancer care, practical patient management, and interprofessional collaboration. Attendees will have the opportunity to earn CE credits while gaining evidence-based strategies to enhance oncology practice and improve communication across the healthcare team.
Register.

Inaugural Oncology Nursing Symposium 2026
2026-03-13 - 2026-03-14 | Embassy Suites by Hilton Charlotte Concord Golf Resort & Spa, 5400 John Q. Hammons Dr NW, Concord, NC, 28027, United States
The Inaugural Oncology Nursing Symposium 2026, hosted by the South Piedmont AHEC in conjunction with Advocate Health, is a crucial two-day, in-person event for nurses, scheduled for March 13–14, 2026.
The symposium will be held at the Embassy Suites by Hilton Charlotte Concord in Concord, North Carolina. This educational gathering is aimed at a wide audience of oncology nurses, including frontline clinicians, nurse leaders, educators, and researchers, and is accredited for a maximum of 7.50 ANCC contact hours.
Agenda and Details.
Register.

2026 CRUSH Colorectal Cancer 5K
2026-03-14 | The River Church, 4425 Ben Franklin Blvd., Durham, NC, 27704, United States
The CRUSH Colorectal Cancer 5K Walk/Run, which supports research at the Duke Cancer Institute, will take place on Saturday, March 14, 2026, at 10:00 a.m.
The event will be held at The River Church. This event aims to raise awareness for colorectal cancer, provide access to colorectal cancer screenings, and feature community exhibitors.

2026 OPN California - Hawaii Chapter Conference
2026-03-14 | Sheraton Park Hotel at the Anaheim Resort, 1855 S Harbor Blvd, Anaheim, CA, 92802, United States
The 2026 OPN California – Hawaii Chapter Conference is a one-day regional summit organized by the Oncology Pharmacy Network (OPN) and Horizon CME, scheduled for March 14, 2026, at the Sheraton Park Hotel at the Anaheim Resort in Anaheim, California, United States.
This event is specifically designed for hematology/oncology pharmacy clinicians (pharmacists, pharmacy technicians, and other healthcare professionals) and focuses on optimizing cancer care by providing the latest evidence-based strategies and fostering networking and collaboration within the community.
Register.

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations
2026-03-15 - 2026-03-18 | Fairmont Le Château Frontenac, 1 Rue des Carrières, Québec, Québec, G1R 5J5, Canada
The Keystone Symposia conference, “Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations,” will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada.
This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, with the goal of guiding strategies to overcome these hurdles and improve clinical outcomes; the sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition, and advanced technologies like spatial imaging and AI.
